Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy
NCT ID: NCT05543863
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2022-08-20
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.
NCT05354856
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer
NCT01215058
Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
NCT02184910
Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer
NCT01002443
Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy
NCT03802006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet function testing
platelet function testing (Platelet function analyzer-100 (PFA-100) collagen epinephrine closure time, VerifyNowⓇ Assays (aspirin, P2Y12)) before surgery and 5 days, 3 months after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are scheduled to undergo distal gastrectomy (access: either minimally invasive surgery or open surgery)
* Patients taking aspirin and/or clopidogrel for primary or secondary prevention for cardiovascular disease or cerebrovascular disease before surgery.
* age 18 - 90 years
* A person who voluntarily agrees to participate in this study and signs the consent form.
Exclusion Criteria
* Patients taking other anticoagulants in combination
* Patients with imparied liver or renal function that may affect drug metabolism.
Impaired liver function: liver cirrhosis Impaired renal function: CKD grade 3 or higher
* Patients requiring adjuvant chemotherapy after surgery that may affect postoperative bone marrow function and hematopoietic function (those with gastric cancer of clinical stage II or more according to the AJCC 8th edition)
* Patients participating in other clinical trials within 6 months
* Vulnerable patients (pregnant women, those with cognitive impairment, etc)
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Chilgok Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Yeon Park
Principle Investigator (Associate professor)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ji Yeon Park, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Surgery, Kyungpook National Univ. Chilgok Hosptal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Surgery, Kyungpook National University Chilgok Hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNUCH 2022-general-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.